Abstract
Septal myectomy has been the gold standard treatment for the relief left ventricular outflow tract obstruction and cardiac symptoms in both adults and children with obstructive hypertrophic cardiomyopathy. In almost all circumstances, abnormalities of the mitral valve and subvalvar mitral apparatus can be managed without the need for mitral valve replacement, and other cardiac lesions can be repaired simultaneously. In the current era, the operative mortality for isolated septal myectomy at an experienced center is low in both children and adults (approximately 1%). Excellent late results with myectomy are gratifying: 90% of patients improve by at least one NYHA class, and improvements persist in most individuals on late follow-up. Late survival in patients with obstructive hypertrophic cardiomyopathy who undergo myectomy exceeds that of patients who do not receive surgical treatment and, in addition, myectomy may be associated with reduced long-term risk of sudden cardiac death. These results should serve as a basis for comparison with newer nonsurgical treatment regimens.
Key Points
-
Septal myectomy relieves left ventricular outflow tract obstruction and cardiac symptoms effectively in both adults and children with obstructive hypertrophic cardiomyopathy
-
Abnormalities of the mitral valve and subvalvar mitral apparatus can be addressed without the need for mitral valve replacement in almost all circumstances, and other cardiac lesions can be repaired at the time of myectomy
-
In experienced centers, the operative mortality and morbidity for isolated septal myectomy in both children and adults is low (approximately 1%) and continues to improve
-
Symptomatic improvement with myectomy is gratifying: 90% of patients improve by at least one NYHA class, and most remain improved on late follow-up
-
Late survival is better in patients with obstructive hypertrophic cardiomyopathy who receive surgery than in those who do not
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nishimura RA et al. (1996) Hypertrophic cardiomyopathy. In Myocardial Disease: Mayo Clinic Practice of Cardiology, 689–711 (Eds Giuliani ER et al.) St Louis: Mosby-Year Book Inc
Goodwin JF et al. (1960) Obstructive cardiomyopathy simulating aortic stenosis. Br Heart J 22: 403–414
Kirklin JW and Ellis FH Jr (1961) Surgical relief of diffuse subvalvular aortic stenosis. Circulation 24: 739–742
Morrow AG and Brockenbrough EC (1961) Surgical treatment of idiopathic hypertrophic subaortic stenosis: technique and hemodynamic results of subaortic ventriculomyotomy. Ann Surg 154: 181
Wigle ED et al. (1962) Idiopathic ventricular septal hypertrophy causing muscular subaortic stenosis. Circulation 26: 325–340
Kelly DT et al. (1966) Results of surgery and hemodynamic observations in muscular subaortic stenosis. J Thorac Cardiovasc Surg 51: 353–365
McIntosh CL and Maron BJ (1988) Current operative treatment of obstructive hypertrophic cardiomyopathy. Circulation 78: 487–495
Mohr R et al. (1989) The outcome of surgical treatment of hypertrophic obstructive cardiomyopathy: experience over 15 years. J Thorac Cardiovasc Surg 97: 666–674
Mohr R et al. (1989) Results of operation for hypertrophic obstructive cardiomyopathy in children and adults less than 40 years of age. Circulation 80 (Suppl 1): 191–196
Williams WG and Rebeyka IM (1992) Surgical intervention and support for cardiomyopathies of childhood. Prog Pediatr Cardiol 1: 61–71
Theodoro DA et al. (1996) Hypertrophic obstructive cardiomyopathy in pediatric patients: results of surgical treatment. J Thorac Cardiovasc Surg 112: 1589–1599
Schulte HD et al. (1993) Prognosis of patients with hypertrophic obstructive cardiomyopathy after transaortic myectomy: late results up to twenty-five years. J Thorac Cardiovasc Surg 106: 709–717
McCully RB et al. (1996) Extent of clinical improvement after surgical treatment of hypertrophic obstructive cardiomyopathy. Circulation 94: 467–471
Wigle ED et al. (1995) Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 92: 1680–1692
Schulte HD et al. (1999) Management of symptomatic hypertrophic obstructive cardiomyopathy—long-term results after surgical therapy. J Thorac Cardiovasc Surg 47: 213–218
Robbins RC and Stinson EB (1996) Long-term results of left ventricular myotomy and myectomy for obstructive hypertrophic cardiomyopathy. J Thorac Cardivasc Surg 111: 586–594
Williams WG et al. (1987) Results of surgery for hypertrophic obstructive cardiomyopathy. Circulation 76: V104–V108
Cohn LH et al. (1992) Long-term follow-up of patients undergoing myotomy/myectomy for obstructive hypertrophic cardiomyopathy. Am J Cardiol 70: 657–660
Maron BJ et al. (2003) American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy—a report of the American College of Cardiology Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines Committee to Develop an Expert Consensus Document on Hypertrophic Cardiomyopathy. J Am Coll Cardiol 42: 1687–1713
Maron BJ (2002) Hypertrophic cardiomyopathy: a systematic review. JAMA 287: 1308–1320
Spirito P et al. (1997) The management of hypertrophic cardiomyopathy. N Engl J Med 336: 775–785
Maron BJ et al. (1999) Assessment of permanent dual-chamber pacing as a treatment for drug-refractory symptomatic patients with obstructive hypertrophic cardiomyopathy: a randomized, double-blind, crossover study (M-PATHY). Circulation 99: 2927–2933
Nishimura RA et al. (1997) Dual-chamber pacing for hypertrophic cardiomyopathy: a randomized, double-blind, crossover trial. J Am Coll Cardiol 29: 435–441
Nishimura RA and Holmes DR (2004) Hypertrophic obstructive cardiomyopathy. N Engl J Med 350: 1320–1327
Dearani JA and Danielson GK (2004) Septal myectomy for hypertrophic cardiomyopathy. Operative Techniques in Thoracic and Cardiovascular Surgery 9: 278–292
Criley JM (1997) Unobstructed thinking (and terminology) is called for in the understanding and management of hypertrophic cardiomyopathy. J Am Coll Cardiol 29: 741–743
Schoendube FA et al. (1995) Long-term clinical and echocardiographic follow-up after surgical correction of hypertrophic obstructive cardiomyopathy with extended myectomy and reconstruction of the subvalvular mitral apparatus. Circulation 92 (9 Suppl): II122–II127
Woo A et al. (2005) Clinical and echocardiographic determinants of long-term survival after surgical myectomy in obstructive hypertrophic cardiomyopathy. Circulation 111: 2033–2041
Maron BJ et al. (1998) Pitfalls in clinical recognition and a novel operative approach for hypertrophic cardiomyopathy with severe outflow obstruction due to anomalous papillary muscle. Circulation 98: 2505–2508
Minakata K et al. (2004) Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae. J Thorac Cardiovasc Surg 127: 481–489
Matsui Y et al. (2000) Mitral valve repair and septal myectomy for hypertrophic obstructive cardiomyopathy. J Cardiovasc Surg 41: 53–56
Joyce F et al. (1994) Treatment of hypertrophic cardiomyopathy by mitral valve repair and septal myectomy. Ann Thorac Surg 54: 1025–1027
Krajcer Z et al. (1988) Mitral valve replacement and septal myectomy in hypertrophic cardiomyopathy: ten-year follow-up in 80 patients. Circulation 78: I35–I43
McIntosh CL et al. (1992) Initial results of combined anterior mitral leaflet plication and ventricular septal myotomy-myectomy for relief of left ventricular outflow tract obstruction in patients with hypertrophic cardiomyopathy. Circulation 86: II60–II67
Van Der Lee C et al. (2003) Sustained improvement after combined anterior mitral leaflet extension and myectomy in hypertrophic obstructive cardiomyopathy. Circulation 108: 2088–2092
Cooley DA (1991) Surgical technique for hypertrophic left ventricular obstructive myopathy including mitral valve plication. J Cardiac Surg 6: 29–33
Matsuda H et al. (1996) Transatrial and transmitral approach for left ventricular myectomy and mitral valve plication for diffuse-type hypertrophic obstructive: a novel approach. J Thorac Cardiovasc Surg 112: 195–196
Heric B et al. (1995) Surgical management of hypertrophic obstructive cardiomyopathy: early and late results. J Thorac Cardiovasc Surg 110: 195–208
Maron BJ et al. (1978) Long-term clinical course and symptomatic status of patients after operation of hypertrophic subaortic stenosis. Circulation 57: 1205–1213
Maron BJ et al. (1983) Symptomatic status and prognosis of patients after operation for hypertrophic obstructive cardiomyopathy: efficacy of ventricular septal myotomy and myectomy. Eur Heart J 4: 175–185
ten Berg JM et al. (1994) Hypertrophic obstructive cardiomyopathy: initial results and long-term follow-up after Morrow septal myectomy. Circulation 90: 1781–1785
Merrill WH et al. (2000) Long-lasting improvement after septal myectomy for hypertrophic obstructive cardiomyopathy. Ann Thorac Surg 69: 1732–1735
Morrow AG et al. (1975) Operative treatment in hypertrophic subaortic stenosis: techniques, and the results of pre and postoperative assessment in 83 patients. Circulation 52: 88–102
Seiler C et al. (1991) Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: a retrospective study. J Am Coll Cardiol 17: 634–645
Firoozi S et al. (2002) Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy: a comparison of clinical, hemodynamic and exercise outcomes. Eur Heart J 20: 1617–1624
Ommen SR et al. (1999) Comparison of dual-chamber pacing versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy: a comparison of objective hemodynamic and exercise and points. J Am Coll Cardiol 34: 191–196
Sherrid MV et al. (2003) Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction. Ann Thorac Surg 75: 620–632
Shah PM et al. (1972) Echocardiographic assessment of the effects of surgery and propranolol on the dynamics of outflow obstruction in hypertrophic subaortic stenosis. Circulation 45: 516–521
Sherrid MV et al. (1993) An echocardiographic study of the fluid mechanics of obstruction in hypertrophic cardiomyopathy. J Am Coll Cardiol 22: 816–824
Maron BJ et al. (1983) Systolic anterior motion of the posterior mitral leaflet: a previously unrecognized cause of dynamic subaortic obstruction in patients with hypertrophic cardiomyopathy. Circulation 68: 282–293
Schapira JN et al. (1978) Single and two-dimensional echocardiographic visualization of the effects of septal myectomy in idiopathic hypertrophic subaortic stenosis. Circulation 58: 850–860
Spirito P et al. (1984) Morphologic determinants of hemodynamic state after ventricular septal myectomy-myectomy in patients with obstructive hypertrophic cardiomyopathy: M-mode and two-dimensional echocardiographic assessment. Circulation 70: 984–995
Franke A et al. (1998) Quantitative assessment of the operative results after extended myectomy and surgical reconstruction of the subvalvular mitral apparatus in hypertrophic obstructive cardiomyopathy using dynamic three-dimensional transesophageal echocardiography. J Am Coll Cardiol 31: 1641–1649
Yu EH et al. (2000) Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy. J Am Coll Cardiol 36: 2219–2225
Wigle ED et al. (1985) Hypertrophic cardiomyopathy: the importance of the site and the extent of hypertrophy: a review. Prog Cardiovasc Dis 28: 1–83
Watson DC et al. (1977) Effects of operation on left atrial size and the occurrence of atrial fibrillation in patients with hypertrophic subaortic stenosis. Circulation 55: 178–181
Ommen SR et al. (2005) Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol 46: 470–476
McKenna W et al. (1981) Prognosis in hypertrophic cardiomyopathy: role of age and clinical, electrocardiographic and hemodynamic features. Am J Cardiol 47: 532–538
Minakata K et al. (2005) Septal myectomy for obstructive hypertrophic cardiomyopathy in pediatric patients: early and late results. Ann Thorac Surg 80: 1424–1430
Minakata K et al. (2005) Mechanisms for recurrent left ventricular outflow tract obstruction after septal myectomy for obstructive hypertrophic cardiomyopathy. Ann Thorac Surg 80: 851–856
Klues HG et al. (1991) Anomalous insertion of papillary muscle directly into anterior mitral leaflet in hypertrophic cardiomyopathy: significance in producing left ventricular outflow obstruction. Circulation 84: 1188–1197
Petrone RK et al. (1992) Coexistence of mitral valve prolapse in a consecutive group of 528 patients with hypertrophic cardiomyopathy assessed with echocardiography. J Am Coll Cardiol 20: 55–61
Klues HG et al. (1992) Diversity of structural mitral valve alterations in hypertrophic cardiomyopathy. Circulation 85: 1651–1660
McIntosh CL et al. (1989) Clinical and hemodynamic results after mitral valve replacement in patients with obstructive hypertrophic cardiomyopathy. Ann Thorac Surg 47: 236–246
ElBardisi A et al.: Septal myectomy after previous septal artery ablation in hypertrophic cardiomyopathy. Mayo Clin Proc, in press
Bruce CJ et al. (1999) Fixed left ventricular outflow tract obstruction in presumed hypertrophic obstructive cardiomyopathy: implications for therapy. Ann Thorac Surg 68: 100–104
Maron BJ et al. (2004) The case for surgery in hypertrophic cardiomyopathy. J Am Coll Cardiol 44: 2044–2053
Dearani JA and Danielson GK (2004) Obstructive hypertrophic cardiomyopathy: results of septal myectomy. In Diagnosis and Management of Hypertrophic cardiomyopathy, 220–353 (Ed Maron BJ) Malden, MA: Blackwell Futura
Acknowledgements
Jacqueline A Hart, Medscape, Boston, MA and Ariana Del Negro, Medscape Cardiology, New York, NY are the authors of and are solely responsible for the content of the learning objectives, questions and answers of the Medscape-accredited continuing medical education activity associated with this article.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Dearani, J., Ommen, S., Gersh, B. et al. Surgery Insight: septal myectomy for obstructive hypertrophic cardiomyopathy—the Mayo Clinic experience. Nat Rev Cardiol 4, 503–512 (2007). https://doi.org/10.1038/ncpcardio0965
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio0965
This article is cited by
-
Is There a Role for Alcohol Septal Ablation in Young Patients with Medically Refractory Hypertrophic Obstructive Cardiomyopathy?
Pediatric Cardiology (2024)
-
Hypertrophic obstructive cardiomyopathy with a basal septal thickness of 16 mm or less: clinical characteristics and surgical results
Surgery Today (2022)
-
Mini-invasive surgical instruments in transaortic myectomy for hypertrophic obstructive cardiomyopathy: a single-center experience with 168 cases
Journal of Cardiothoracic Surgery (2021)
-
Phenotypes of hypertrophic cardiomyopathy: genetics, clinics, and modular imaging
Heart Failure Reviews (2021)
-
Septuagenarians with hypertrophic obstructive cardiomyopathy undergoing myectomy: the experience of a single center
Surgery Today (2021)